Home
STAY INFORMED
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.

     

COMPANY PAGE

Login Latest update: 12-04-2018
Verseon

 
Contact
Verseon Corporation is a technology-based pharmaceutical company that pairs a proprietary, computational drug discovery platform with a comprehensive chemistry and biology workflow to develop novel therapeutics that are unlikely to be found using conventional methods. Verseon has four active drug programs in the areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The anticoagulation program is scheduled to enter phase I clinical trials in 2018.
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
SIGN UP FOR OUR NEWSLETTER
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertisingControl panel log-in